P. Feige et al.
DCM and 2 cm3 water was added. The mixture was
extracted with DCM (3 9 5 cm3) and the combined
organic phases were dried over MgSO4. The solvent was
evaporated under reduced pressure and the residue was
purified through silica gel flash column chromatography
(hexane/EtOAc = 6/1) to yield the desired aminoaldehy-
des 2.
5,5-Diphenyl-1-tosylpiperidin-3-yl pivalate
(3a, C29H33NO4S)
Following the general protocol B, compound 3a was
isolated in 86% yield. 1H NMR (500 MHz, CDCl3):
d = 7.63 (d, J = 8.3 Hz, 2H), 7.45 (d, J = 7.5 Hz, 2H),
7.36–7.29 (m, 4H), 7.26–7.15 (m, 6H), 4.80 (tt, J = 9.4,
4.5 Hz, 1H), 4.30 (d, J = 12.2 Hz, 1H), 3.69 (dd,
J = 10.5, 4.3 Hz, 1H), 2.90 (dt, J = 12.7, 1.8 Hz, 1H),
2.82 (d, J = 12.2 Hz, 1H), 2.49 (t, J = 9.9 Hz, 1H), 2.42
(s, 3H), 2.05 (dd, J = 12.8, 10.2 Hz, 1H), 1.10 (s, 9H)
ppm; 13C NMR (125 MHz, CDCl3): d = 178.1, 146.5,
144.5, 144.0, 133.4, 130.5, 129.4, 129.2, 128.5, 128.3,
127.3, 127.2, 127.2, 54.8, 49.9, 46.9, 40.3, 39.3, 27.8, 27.7,
5,5-Diphenyl-1-tosylpiperidin-3-yl formate
(2a, C25H25NO4S)
Following the general protocol A, compound 2a was
isolated in 79% yield. 1H NMR (500 MHz, CDCl3):
d = 7.91 (s, 1H), 7.64 (d, J = 8.0 Hz, 2H), 7.49 (d,
J = 7.7 Hz, 2H), 7.38–7.14 (m, 10H), 4.92 (tt, J = 9.8,
4.1 Hz, 1H), 4.46 (d, J = 12.5 Hz, 1H), 3.91–3.86 (m, 1H),
2.93 (dt, J = 12.6, 1.7 Hz, 1H), 2.63 (d, J = 12.5 Hz, 1H),
2.43 (s, 3H), 2.40 (d, J = 7.1 Hz, 1H), 2.18–2.10 (m, 1H)
ppm; 13C NMR (125 MHz, CDCl3): d = 160.3, 146.2,
144.7, 143.6, 133.1, 130.5, 129.4, 129.2, 128.4, 128.3,
127.4, 127.3, 127.1, 67.6, 54.6, 49.8, 47.0, 40.4, 22.2 ppm;
ꢀ
27.7, 22.2 ppm; IR (film): m = 2971, 1728, 1598, 1496,
1479, 1447, 1346, 1282, 1161, 1090, 1038, 1020, 991, 910,
804, 783, 732, 699, 663, 570, 549 cm-1; HRMS (ESI): m/z
calcd for C29H33NNaO4S 514.20225, found 514.20233.
5,5-Dimethyl-1-tosylpiperidin-3-yl pivalate
(3b, C19H29NO4S)
ꢀ
Following the general procedure for the gold-catalyzed
difunctionalization of alkenes, compound 2b was isolated
IR (film): m = 2925, 2366, 1723, 1598, 1496, 1447, 1345,
1162, 1090, 1011, 908, 779, 730, 699, 661, 578, 562,
550 cm-1; HRMS (ESI): m/z calcd for C25H25NNaO4S
458.13965, found 458.13970.
1
in 80% yield. H NMR (500 MHz, CDCl3): d = 7.64 (d,
J = 8.0 Hz, 2H), 7.32 (d, J = 7.9 Hz, 2H), 5.02–4.91 (m,
1H), 3.40 (dd, J = 11.4, 3.9 Hz, 1H), 2.90 (d,
J = 11.4 Hz, 1H), 2.62 (dd, J = 11.3, 7.8 Hz, 1H), 2.50
(d, J = 11.4 Hz, 1H), 2.43 (s, 3H), 1.64 (dd, J = 13.3,
4.3 Hz, 1H), 1.23 (dd, J = 13.4, 8.2 Hz, 1H), 1.18 (s, 9H),
1.04 (s, 6H) ppm; 13C NMR (125 MHz, CDCl3):
d = 177.7, 143.6, 134.0, 129.8, 127.7, 66.7, 57.0, 49.2,
41.8, 38.8, 31.7, 27.9, 27.2, 26.2, 21.7 ppm; IR (film):
5,5-Dimethyl-1-tosylpiperidin-3-yl formate
(2b, C15H21NO4S)
Following the general protocol A, compound 2b was
isolated in 67% yield. 1H NMR (500 MHz, CDCl3):
d = 7.99 (s, 1H), 7.63 (d, J = 8.4 Hz, 2H), 7.33 (d,
J = 8.0 Hz, 2H), 5.14 (tt, J = 8.8, 4.5 Hz, 1H), 3.65 (dd,
J = 11.2, 4.4 Hz, 1H), 3.07 (d, J = 11.5 Hz, 1H), 2.48–
2.44 (m, 1H), 2.43 (s, 3H), 2.31 (d, J = 11.5 Hz, 1H), 1.73
(dd, J = 13.2, 4.5 Hz, 1H), 1.22 (dd, J = 13.2, 9.5 Hz,
1H), 1.07 (s, 3H), 1.00 (s, 3H) ppm; 13C NMR (125 MHz,
CDCl3): d = 160.6, 144.4, 134.2, 130.4, 128.2, 67.5, 57.5,
ꢀ
m = 2969, 1736, 1455, 1366, 1348, 1307, 1282, 1228,
1216, 1206, 1161, 1092, 1036, 992, 916, 813, 767, 752,
685, 660, 549 cm-1; HRMS (ESI): m/z calcd for C19H29-
NNaO4S 390.1715, found 390.17130.
ꢀ
5,5-Diphenyl-1-tosylpiperidin-3-yl 2,2,2-trifluoroacetate
(4a, C16H20F3NO4S)
49.7, 42.6, 32.5, 28.7, 26.1, 22.2 ppm; IR (film): m = 2958,
1721, 1598, 1469, 1343, 1307, 1158, 1092, 993, 966, 916,
815, 660, 583, 551 cm-1; HRMS (ESI): m/z calcd for
C15H21NNaO4S 334.10835, found 334.10830.
Following the general protocol B, compound 4a was
isolated in 80% yield. 1H NMR (500 MHz, CDCl3):
d = 7.83 (d, J = 8.2 Hz, 2H), 7.65 (d, J = 7.6 Hz, 2H),
7.56–7.49 (m, 4H), 7.46–7.30 (m, 6H), 5.14 (tt, J = 9.9,
4.3 Hz, 1H), 4.65 (d, J = 12.5 Hz, 1H), 4.12 (dd,
J = 10.5, 4.8 Hz, 1H), 3.16 (dt, J = 12.6, 1.8 Hz, 1H),
2.81 (d, J = 12.5 Hz, 1H), 2.64 (t, J = 10.2 Hz, 1H), 2.61
(s, 3H), 2.40 (dd, J = 12.5, 10.8 Hz, 1H) ppm; 13C NMR
(125 MHz, CDCl3): d = 157.0 (q, J = 42.7 Hz), 145.7,
144.9, 143.1, 133.0, 130.7, 129.6, 129.4, 128.5, 128.3,
127.8, 127.5, 127.0, 114.9 (q, J = 285.8 Hz), 72.2, 54.6,
General protocol B
A mixture of aminopent-4-ene (1, 1 equiv.), oxidant
(2 equiv.), and NaHCO3 (1 equiv.) was dissolved in 1,2-
dichloroethane (0.1 M) followed by addition of Ph3-
PAuSbF6 (0.05 equiv.). The reaction was stirred for 2 h
at 80 °C and was monitored by TLC. Upon consumption
of the starting material, the mixture was diluted with
5 cm3 DCM and filtered over celite. The solvent was
evaporated under reduced pressure and the residue was
purified through silica gel flash column chromatography
(hexane/EtOAc = 10/1) to yield the desired aminoesters
3–6.
ꢀ
49.3, 47.1, 40.0, 22.2 ppm; IR (film): m = 2852, 1784,
1598, 1496, 1448, 1347, 1221, 1158, 1091, 1009, 908, 864,
816, 803, 781, 733, 698, 662, 578, 550 cm-1; HRMS
(ESI): m/z calcd for C26H24F3NNaO4S 526.12703, found
526.12763.
123